| Risk factors associated with all-cause 30-day mortality in nursing home residents with COVID-19 OA Panagiotou, CM Kosar, EM White, LE Bantis, X Yang, ... JAMA Internal Medicine 181 (4), 439-448, 2021 | 193 | 2021 |
| Association between combined TMPRSS2: ERG and PCA3 RNA urinary testing and detection of aggressive prostate cancer MG Sanda, Z Feng, DH Howard, SA Tomlins, LJ Sokoll, DW Chan, ... JAMA oncology 3 (8), 1085-1093, 2017 | 141 | 2017 |
| Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity M Capello, JV Vykoukal, H Katayama, LE Bantis, H Wang, DL Kundnani, ... Nature communications 10 (1), 254, 2019 | 137 | 2019 |
| Sequential validation of blood-based protein biomarker candidates for early-stage pancreatic cancer M Capello, LE Bantis, G Scelo, Y Zhao, P Li, DS Dhillon, NJ Patel, ... JNCI: Journal of the National Cancer Institute 109 (4), djw266, 2017 | 132 | 2017 |
| Quantitative imaging to evaluate malignant potential of IPMNs AN Hanania, LE Bantis, Z Feng, H Wang, EP Tamm, MH Katz, A Maitra, ... Oncotarget 7 (52), 85776, 2016 | 132 | 2016 |
| Construction of confidence regions in the ROC space after the estimation of the optimal Youden index-based cut-off point LE Bantis, CT Nakas, B Reiser Biometrics 70 (1), 212-223, 2014 | 121 | 2014 |
| A plasma-derived protein-metabolite multiplexed panel for early-stage pancreatic cancer JF Fahrmann, LE Bantis, M Capello, G Scelo, JB Dennison, N Patel, ... JNCI: Journal of the National Cancer Institute 111 (4), 372-379, 2019 | 105 | 2019 |
| Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins F Guida, N Sun, LE Bantis, DC Muller, P Li, A Taguchi, D Dhillon, ... JAMA Oncology, e182078-e182078, 2018 | 105 | 2018 |
| Reducing ovarian cancer mortality through early detection: approaches using circulating biomarkers CV Trinidad, AL Tetlow, LE Bantis, AK Godwin Cancer Prevention Research 13 (3), 241-252, 2020 | 56 | 2020 |
| Rapid effects of humidity acclimation on stress resistance in Drosophila melanogaster DD Aggarwal, P Ranga, B Kalra, R Parkash, E Rashkovetsky, LE Bantis Comparative Biochemistry and Physiology Part A: Molecular & Integrative …, 2013 | 36 | 2013 |
| Construction of confidence intervals for the maximum of the Youden index and the corresponding cutoff point of a continuous biomarker LE Bantis, CT Nakas, B Reiser Biometrical Journal 61 (1), 138-156, 2019 | 33 | 2019 |
| Inference in generalized linear regression models with a censored covariate JV Tsimikas, LE Bantis, SD Georgiou Computational Statistics & Data Analysis 56 (6), 1854-1868, 2012 | 32 | 2012 |
| Combining multiple biomarkers linearly to maximize the partial area under the ROC curve Q Yan, LE Bantis, JL Stanford, Z Feng Statistics in medicine 37 (4), 627-642, 2018 | 30 | 2018 |
| Contribution of a blood-based protein biomarker panel to the classification of indeterminate pulmonary nodules EJ Ostrin, LE Bantis, DO Wilson, N Patel, R Wang, D Kundnani, ... Journal of Thoracic Oncology 16 (2), 228-236, 2021 | 25 | 2021 |
| Construction of joint confidence regions for the optimal true class fractions of Receiver Operating Characteristic (ROC) surfaces and manifolds LE Bantis, CT Nakas, B Reiser, D Myall, JC Dalrymple-Alford Statistical methods in medical research, 0962280215581694, 2017 | 25 | 2017 |
| Comparison of two correlated ROC curves at a given specificity or sensitivity level LE Bantis, Z Feng Statistics in medicine 35 (24), 4352-4367, 2016 | 25 | 2016 |
| Survival estimation through the cumulative hazard function with monotone natural cubic splines LE Bantis, JV Tsimikas, SD Georgiou Lifetime data analysis 18, 364-396, 2012 | 15 | 2012 |
| Effects of weight loss and weight regain on circulating biomarkers in overweight/obese breast cancer survivors enrolled in a weight loss trial in the rural midwest CA Befort, BF Kimler, LE Bantis, TA Phillips, CJ Fabian Cancer Epidemiology, Biomarkers & Prevention 29 (7), 1321-1328, 2020 | 14 | 2020 |
| Reducing ovarian cancer mortality through early detection: approaches using circulating biomarkers. Cancer Prev. Res. 2020; 13: 241–252. doi: 10.1158/1940-6207 CV Trinidad, AL Tetlow, LE Bantis, AK Godwin CAPR-19-0184.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 14 | |
| CES2 Expression in pancreatic adenocarcinoma is predictive of response to irinotecan and is associated with type 2 diabetes M Capello, JF Fahrmann, MV Rios Perez, JV Vykoukal, E Irajizad, ... JCO Precision Oncology 4, 426-436, 2020 | 13 | 2020 |
Ziding FengProfessor of Biostatistics, Fred Hutchinson Cancer Research CenterVerified email at fredhutch.org
